Ligand Pharmaceuticals
LGND | NASDAQ
$290.07
+$6.58 (+2.32%)
At close: Sep 21, 2026, 4:00 PM ET
$293.40
+$3.33 (+1.15%)
Pre-market:
Sep 22, 2026, 4:54 AM ET
Employees
47
Change (1Y)
-21
Growth (1Y)
-30.88%
Revenue / Employee
$6,181,745
Profits / Employee
$4,196,170
Market Cap
$5.81B
Employees History
| Date | Employees | Change | % Change |
|---|---|---|---|
| Dec 31, 2025 | 47 | -21 | -30.88% |
| Dec 31, 2024 | 68 | 10 | +17.24% |
| Dec 31, 2023 | 58 | -18 | -23.68% |
| Dec 31, 2022 | 76 | -78 | -50.65% |
| Dec 31, 2021 | 154 | -1 | -0.65% |
| Dec 31, 2020 | 155 | 40 | +34.78% |
| Dec 31, 2019 | 115 | -1 | -0.86% |
| Dec 31, 2018 | 116 | 77 | +197.44% |
| Dec 31, 2017 | 39 | 17 | +77.27% |
| Dec 31, 2016 | 22 | 1 | +4.76% |
| Dec 31, 2015 | 21 | 2 | +10.53% |
| Dec 31, 2014 | 19 | -1 | -5.00% |
| Dec 31, 2013 | 20 | -1 | -4.76% |
| Dec 31, 2012 | 21 | 0 | 0.00% |
| Dec 31, 2011 | 21 | -10 | -32.26% |
| Dec 31, 2010 | 31 | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove LGND